For leptin and overall prostate cancer, the overall fixed effect OR was consistent with the null hypothesis (OR 1.00, 95% CI 0.98 to 1.02 per 2.5 ng/ml increase in leptin, p = 0.84) (Fig. 2a). The gene discussed is LEP; the disease is prostate carcinoma.